Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
about
Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyHampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerAlloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicityThe spleen in local and systemic regulation of immunityPro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedMyeloid-derived cells are key targets of tumor immunotherapyCutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway.Very small size proteoliposomes abrogate cross-presentation of tumor antigens by myeloid-derived suppressor cells and induce their differentiation to dendritic cellsTracking of intertissue migration reveals the origins of tumor-infiltrating monocytes.Mutant KRAS promotes malignant pleural effusion formation.The journey from stem cell to macrophage.Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axisCancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination.Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesChronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth.Molecular pathways: myeloid complicity in cancer.Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinomaSynchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A case-control study.Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune responseComplexity and challenges in defining myeloid-derived suppressor cellsTumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent mannerAxitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response.Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy.6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.Tumor-host signaling interaction reveals a systemic, age-dependent splenic immune influence on tumor development.Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.MicroRNA-mediated control of macrophages and its implications for cancerInflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.Dynamics of the spleen and its significance in a murine H22 orthotopic hepatoma model.Immunological off-target effects of standard treatments in gastrointestinal cancersThe intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes.In vivo immune cell distribution of gold nanoparticles in naïve and tumor bearing mice.Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer.T-cell tolerance in cancer.Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly.
P2860
Q26779184-97888AE7-BD37-4E05-8252-AAF542360F25Q26863418-BC8077D1-53E9-4C94-B53A-B43346C8B710Q26866323-CE51BE64-F5D1-483E-BF07-71FB6E7C4EF4Q27025001-F113BA50-CAD9-4465-AE1C-181C6A68D70AQ28076161-AA495A1D-98D5-4556-8EA7-DEB765F1B678Q28084627-3B3F3F52-2798-4BB0-B69C-FEF9F58938BFQ28388246-A44B9386-271F-4657-A9A8-61FD834907A2Q30235983-6DEF2E79-E311-4178-AC01-10D9AFBE2C98Q30411026-07BF00A0-E681-4815-9EFA-CA3367A7562AQ33606156-FF408B1D-CEEA-470C-AED0-74AECFD63906Q33694661-36212BD2-992B-4654-BC5F-1E0D5FC18150Q33716297-5C4A7DB6-6C67-4411-A126-5C322F5CA515Q33817936-95FCADC1-56F7-4449-A828-65BE10ECCB18Q33838944-9DC58D5F-D556-479C-A063-FA6BF79CEEF7Q33954123-97AF91D1-B4E2-4649-BAC0-8FBB73B82996Q34044797-CD3026BB-B8B6-4C5F-99D8-5FE4E608DBC3Q34579989-403650E0-8F17-49B8-BA4E-9E2F3E2A7DB7Q34725969-B12B935A-814F-4765-9510-90D5265EF5C1Q35067627-01F57C4E-985D-42C2-BC79-2174ED5A11BBQ35128168-01D0F142-3F8E-4094-BBA5-7218D5248BC6Q35201890-1EA20752-8F0C-4D0A-8DC4-6A97A9129FA3Q35509317-1FC43429-8AB1-44DD-94FD-652C1678763DQ35586581-F9611CA2-71FD-4798-890A-7FE880318FAFQ35798966-A8BB00B3-581B-4870-93D4-396D3F762403Q35799198-1E185501-1AC5-4770-B8CA-FCB25FB89E12Q35849774-36DA9169-7B55-4F17-9BE0-CA102B62EB42Q35863346-1EB9DB0D-FDBC-47C6-9C60-24AEEC6D0557Q35886450-94E0F2DB-C9CB-4C18-BAF0-51C7327DFB8CQ36546383-AE69C7F9-3E27-40BC-87AC-5B04782E5D16Q36745336-5618219F-E8C7-4F7A-AF96-E3F8D9980C26Q36980007-624DDCDA-09DE-4197-BD39-5E1834AD81A9Q36980064-908EACA7-5C93-45B5-85C3-9070F714F298Q37107253-BDA7E74D-E22B-4A38-8A26-EB46BC272BC9Q37404086-7B848FEB-A439-4C82-8A86-3BD256885AF0Q37518395-A5DB301D-0807-4DF6-BD1C-C2228AB58279Q37544847-E727C97B-09CA-462A-BDC8-22A61AAC7410Q37656558-F7AF01C8-BF7A-4BC4-A4D1-1B776C83AD8FQ38083001-92E178F6-14D5-4197-B588-A243206A8205Q38103582-A106D1A1-8310-4C6F-8F2A-275F78998AA9Q38160782-BDE5C6F1-A657-41DE-B843-C6946D6297C4
P2860
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
@en
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
@nl
type
label
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
@en
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
@nl
prefLabel
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
@en
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
@nl
P2093
P50
P1433
P1476
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.
@en
P2093
Anna Cabrelle
Elisa Peranzoni
Giacomo Desantis
Mariacristina Chioda
Steffen Walter
Toni Weinschenk
Vincenzo Bronte
P304
P356
10.1016/J.CELREP.2012.08.006
P577
2012-09-06T00:00:00Z